Clinical Trials
9 trialsNCT04865679 2026-06-03
REPOSE-XLâ„
Axogen Corporation
Phase NA Active not recruiting
NCT06848348 2026-05-29
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Dogwood Therapeutics Inc.
Phase 2 Recruiting
NCT04287075 2024-03-26
Rethink Pain
Axogen Corporation
Terminated
NCT02073474 2022-12-20
An Observational Post-Marketing Safety Registry of Sativex®
Jazz Pharmaceuticals
Completed
NCT01236053 2017-07-06
Cancer in Patients With Gabapentin (GPRD)
GlaxoSmithKline
Completed
NCT01138124 2017-05-30
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)
GlaxoSmithKline
Completed
NCT03105765 2017-04-10
Acute and Chronic Pain, Especially Neuropathic Pain, After Thoracotomy and Continuous Application of Ketamine.
Dr. Horst Schmidt Klinik GmbH
Phase NA Completed
NCT00474916 2010-08-16
Neuropathic Pain in Patients With Cancer
DARA Therapeutics
Phase 2 Completed
NCT00911261 2010-02-15
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
Endo Pharmaceuticals
Phase 3 Completed